Andrew Yelland FRCS
Mr. Yelland is a highly experienced surgeon who has spent literally decades studying the art and science of cosmetic surgery.
Mr. Yelland received his MB BS from the University of London (St. George's Hospital) in 1986, and trained in the highly regarded breast reconstructive units of St. George's Hospital, The Royal Surrey County Hospital in Guildford and Royal Marsden Hospitals in London and Sutton.
He spent 1990 - 1991 at St. George's Hospital Medical School and Charing Cross Hospital Medical School investigating the role of growth factors in breast cancer. As a result of this work he was awarded a Master of Surgery degree from the University of London.
In 1991 he became a Fellow of the Royal College of Surgeons in Edinburgh and in 2001 a Fellow of the Royal College of Surgeons of England.
Pursuing his interest in cosmetic surgery and breast reconstruction, Mr. Yelland traveled to Atlanta, Georgia in the USA to study at Emory University, whose Plastic and Reconstructive Unit is known for its pioneering efforts in breast reconstruction and new endoscopic plastic surgical techniques.
Today, Mr. Yelland is a Lead Consultant in Breast Surgery at Brighton & Sussex University Hospitals NHS Trust, with a special interest in cosmetic and related onco-plastic procedures, and a highly regarded cosmetic surgeon.
Areas of special interest
Over his years of practice, Mr. Yelland has developed a special interest in certain kinds of cosmetic surgery. His four major areas of interest are:
- Cosmetic breast surgery, including breast enlargement, reduction and uplift as well as surgery for inverted nipples and male breast reduction (Gynecomastia)
- Abdominal reshaping, including liposuction, liposculpture and abdominoplasty (also called Tummy Tuck or Minituck surgery)
- Facial rejuvenation, including Botox ?, Restylane ? and lip enhancement.
- Breast reconstruction, including LD flaps, SM expander and TRAM.
Membership in medical societies
Mr. Yelland also joins with his peers to share knowledge and advance their various disciplines through a number of prestigious medical societies, including:
- American Academy of Cosmetic Surgery
- American Society of Liposuction Surgery
- European Academy of Cosmetic Surgery
- European Society of Surgical Oncology
- British Medical Association
- Hospital Consultants & Specialists Association
- Brighton & Sussex Medico-Chirurgical Society
- British Association of Surgical Oncology
- British Association of Sclerotherapists
- Association of Breast Surgeons
- Royal Society of Medicine (Plastic Surgery, Surgery, Oncology)
Ongoing professional development
As a surgeon and a scientist, Mr. Yelland continues to explore new technologies and share insights and experience with his colleagues through educational workshops, courses and meetings. Examples of these efforts include:
- Advanced Course in Breast Reconstruction
- Management of Breast Disease Course
- Fundamental Techniques in Breast Reconstruction
- State of the Art Surgery for Breast Specialists
- Breast Augmentation Workshop
- International Masterclass in Cosmetic Breast Surgery
- Tumescent Liposuction Course
- Millennium Masterclass in Breast Reconstruction
- Surgical Workshop in Breast Reduction
- Botox Study Workshop
- Masters Meeting (Cosmetic Surgery)
- American Society of Clinical Oncology (Annual Meeting)
- Interprofessional Masterclass for Breast Reconstruction
- Global Breast Cancer Summit
- Masterclass - Current Trends in Breast Reconstruction
- Aesthetic Surgery of the breast & trunk
- What's new in oncoplastic breast surgery
- Sentinel Node Biopsy Training Course
- Advanced Plastic Surgery of the Breast
- Aesthetic Surgery of the Breast: Safe Surgical Approach
- British Association of Sclerotherapy
Hospitals
Mr Yelland consults and operates at the Nuffield Health Brighton and Haywards Heath Hospitals.
Nuffield Health Brighton Hospital has 56 private bedrooms with en suite facilities, 3 state of the art operating theatres and 10 consulting rooms. It also has a 24 hour resident medical cover.
Nuffield Health Haywards Heath Hospital, has 42 private bedrooms with en suite facilities, 2 operating theatres, 8 consulting rooms and 24 hour resident medical cover.
All three hospitals are of course fully registered with the Healthcare commission.
Mr Yelland lives locally and over the last 10 years has developed expert teams for cosmetic surgery in both the out-patient and operating suites.
Sample publications of cosmetic surgery
Radiotherapy & Tamoxifen in Women with Completely Excised DCIS
Lancet 2003; 362:1154
The Use of Neo-Adjuvant CMF Chemotherapy to Avoid Mastectomy
European Journal of Surgical Oncology 1999:25; 50-53
The use of the latissimus dorsi musculocutaneous flap for immediate correction of the deformity resulting from breast conservation therapy
British Journal of Plastic Surgery 1999; 52:420-421
Initial experience of intramammary prostheses in breast conserving surgery
European Journal of Surgical Oncology 1999; 25:638
Conservative Management of Fibroadenoma of the Breast
British Journal of Surgery, 1996; 83:1653
Acidic and basic fibroblast growth factors in human breast tissue
European Journal of Cancer 1994; 30A(4):496-503
Bilateral Breast Carcinoma
European Journal of Surgical Oncology 1993; 19: 259-264
Diagnosing Breast Carcinoma in Young Women
British Medical Journal 1991; 302: 618-620
Forward - Mastalgia
Targeted Therapeutic News: No 49, December 1999
Breast Reconstruction
Sussex Life Magazine, February 1997
Breast Care - Consultation, Diagnosis & Treatment
Brighton & Hove Life, June 2000
Management of localised ductal carcinoma in situ (DCIS) by breast conserving surgery without adjuvant therapy
Poster 40, BASO Annual Conference, November 2004*
Core Biopsy: Predictive value in postoperative chest wall radiotherapy & selection for implant based immediate breast reconstruction
Poster 17, BASO Annual Conference, London 2002
Specimen-Orientated X-Rays in the Assessment of Resection Margin in Conservative Surgery of Palpable Invasive Breast Cancer
Nottingham International Breast Cancer Conference, September 2001
Mastectomy for Ductal Carcinoma In Situ: Is Synchronous Axillary node sampling Appropriate?
Nottingham International Breast Cancer Conference, September 1999
Atypical Ductal Hyperplasia detected by Core Biopsy - Correlation with subsequent Excisional Histology.
Nottingham International Breast Cancer Conference, September 1999
Using Vascular Embolisation Coils As A Metal Marker Inserted Percutaneously Directly into Breast Cancers to identify Their Position Prior to Chemotherapy - Preliminary Report.
Nottingham International Breast Cancer Conference, September 1999
Development and Implementation of a departmental database system - Implications for assessing and improving the management of breast cancer.
Nottingham International Breast Cancer Conference, September 1997
